ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
Project Title | Institution / Principal Investigator(s) | Grant Type | Year | State |
---|---|---|---|---|
Novel targeting approach for pediatric B-cell malignancies | Thomas Jefferson University / Christine Eischen, PhD | Innovation Grants | 2021 | Pennsylvania |
Mechanisms Regulating Medulloblastoma Progression | University of Pennsylvania / Nadia Dahmane, PhD | Innovation Grants | 2013 | Pennsylvania |
Development of Immunostimulatory DNA as a Novel Therapy in Pediatric Acute Lymphoblastic Leukemia | Children’s Hospital of Philadelphia / Alix Seif, MD, MPH | Young Investigator Grants | 2008 | Pennsylvania |
Cancer Risk and Incidence in Beckwith-Wiedemann Syndrome | Children’s Hospital of Philadelphia / Jennifer Kalish, MD/PhD | Epidemiology Grants | 2019 | Pennsylvania |
Multivalent Nanomedicine to Treat High-Risk Pediatric Solid Tumors | Children’s Hospital of Philadelphia / Garrett Brodeur, MD | Reach Grants | 2019 | Pennsylvania |
The Tumor Suppressive Role of LNK (SH2B3) in Acute Lymphoblastic Leukemia | Children’s Hospital of Philadelphia / Wei Tong, PhD | Innovation Grants | 2014 | Pennsylvania |
Targeting MYCN | Children’s Hospital of Philadelphia / Yael Mossé, MD & Julie Park, MD | Crazy 8 Pilots | 2019 | Pennsylvania |
Epigenomic Mechanisms of Neuroblastoma Tumorigenesis | Children’s Hospital of Philadelphia / Jo Lynne Harenza, PhD | Young Investigator Grants | 2017 | Pennsylvania |
Tumor cell hybridoma vaccine for recurrent neuroblastoma and Ewing sarcoma | The Pennsylvania State University / Ken Lucas, MD | Innovation Grants | 2006 | Pennsylvania |
BH3 profiling to define therapy resistance classes in neuroblastoma. | Children’s Hospital of Philadelphia / Michael Hogarty | Innovation Grants | 2009 | Pennsylvania |